InspireMD, Inc.
NSPR- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001433607
No open-market purchases or sales by InspireMD, Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $17.4M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +2 vs. previous quarter
- 37
- 13F valueReported value at the end of Q2 2026
- $17.4M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding NSPR, Q2 2026
No superinvestor reported holding NSPR at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by InspireMD, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 29, 2026 (view filing) | May 27 | 2 days | Stuka PaulDirector | PPurchase | +20.0K | $0.88 | +$17.6K | +3.1%667.9K after | |
| May 21, 2026 (view filing) | Jan 27, 2025-May 19, 2026 | 479 daysLate | Gleason Shane ThomasChief Commercial Officer | SSale | −85.3K | $2.22 | −$189.6K | −7.5%1.05M after | 14 lots |
| May 15, 2026 (view filing) | May 13-14 | 2 days | Stuka PaulDirector | PPurchase | +15.0K | $1.16 | +$17.4K | +2.4%647.9K after | 2 lots |
| May 13, 2026 (view filing) | May 12 | 1 day | Slosman MarvinCEO and President | PPurchase | +21.0K | $1.20 | +$25.2K | +0.6%3.56M after | |
| May 13, 2026 (view filing) | May 8-11 | 5 days | Stuka PaulDirector | PPurchase | +75.6K | $1.16 | +$88.0K | +13.6%632.9K after | Amended2 lots |
| May 8, 2026 (view filing) | May 6-7 | 2 days | Ward Scott R.Director | PPurchase | +89.3K | $1.15 | +$102.6K | +60.4%237.1K after | 2 lots |
| May 8, 2026 (view filing) | May 6-7 | 2 days | Stuka PaulDirector | PPurchase | +7.89K | $1.14 | +$9.03K | +1.5%531.6K after | 2 lots |
| May 8, 2026 (view filing) | May 7 | 1 day | Roubin Gary SDirector | PPurchase | +90.0K | $1.18 | +$106.2K | +12.1%834.5K after | |
| Feb 23, 2026 (view filing) | Dec 9, 2025 | 76 days | Stuka PaulDirector | PPurchase | +2.71K | $1.81 | +$4.91K | +0.7%391.6K after | Amended |
| Feb 2, 2026 (view filing) | Jan 15-Feb 2 | 18 daysLate | Gleason Shane ThomasChief Commercial Officer | SSale | −61.2K | $1.62 | −$99.2K | −5.1%1.14M after | 10 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in InspireMD, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 6,752,968 | $4.73M | 0.14% | +3,376,484+100.0% | Added |
| Rosalind Advisors, Inc. | 3,905,743 | $2.73M | 1.03% | 00.0% | Unchanged |
| Standard Life Aberdeen plc | 3,698,364 | $2.59M | 0.00% | +525,000+16.5% | Added |
| OrbiMed Advisors LLC | 3,133,405 | $2.19M | 0.04% | 00.0% | Unchanged |
| Parkman Healthcare Partners LLC | 2,416,518 | $1.69M | 0.17% | 00.0% | Unchanged |
| Marshall Wace, LLP | 1,860,405 | $1.30M | 0.00% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 1,045,708 | $732.1K | 0.03% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 450,517 | $315.4K | 0.85% | 00.0% | Unchanged |
| Ingalls & Snyder LLC | 368,800 | $258.0K | 0.01% | −10,500−2.8% | Reduced |
| Affiance Financial, LLC | 250,370 | $175.3K | 0.03% | 00.0% | Unchanged |